The GEO Group, Inc. (GEO): what the price requires

At today's price, The GEO Group, Inc. (GEO) is priced for +17.9% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/GEO

Headline

FieldValue
TickerGEO
CompanyThe GEO Group, Inc.
Current price$30.18/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed9.6%
Operating margin today10.0%
Margin compression implied-0.4pp
Implied growth17.9%
Multiple paid22x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 9.1% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7.2pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.78σ
sustained it ~5 years at this level40%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.36x5expensive
Earnings1.42x3expensive
Relative0.90x5justifies
Growth1.11x2expensive

Families that justify the price: Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.1%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00noFCF base $0.0B, growth 13% (input: historical growth), terminal g 4.0%, WACC 7.1%, 6yr projection
DCF Exit MultipleGrowth$29.541.02xyesExit EV/EBITDA: 11.4x / 13.4x / 15.4x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$33.590.90xyesP/E 18x (static sector reference · 2026-04), scenarios: 14.8x / 18.0x / 21.2x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$22.031.37xyesBV/sh $11.18, ROE (TTM) 18.2%, ke 9.3%
Two-Stage Excess ReturnAsset$30.530.99xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$25.091.20xyesRev $2.7B, growth 13% (input: historical growth; tapered), Terminal P/S: 1.2x / 1.5x / 1.7x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$23.641.28xyesEPS $1.97, growth 2% (input: historical EPS growth), PEG=7.41 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$13.332.26xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.32B × (1−21%) / WACC 7.1% → EPV (no growth)
Residual IncomeAsset$30.261.00xyesBV $11.18 + 5yr PV of (ROE (TTM) 18.2% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$22.261.36xyes√(22.5 × EPS $1.97 × BVPS $11.18) — Graham's conservative floor
EV/EBITDA RelativeRelative$25.781.17xyesEBITDA $0.42B × sector EV/EBITDA 12.0x
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$63.570.47xyesEPS $1.97 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$3.618.36xyesBV $11.18 × (ROIC 2.3% / WACC 7.1%)
P/Sales SectorRelative$50.950.59xyesRevenue $2.73B × sector P/S 2.5x
PEG Fair ValueRelative$73.880.41xyesEPS $1.97 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$21.301.42xyesEPS $1.97 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$1.6b
Net debt / NOPAT (after-tax)7.66x
Net debt / operating income (pre-tax)6.05x
Interest coverage1.6x
Share count CAGR (dilution)2.5%
Burning cashno

Bullet Takeaways

Bull Case

Look at where the $29.27 price sits against the valuation methods and the read is balanced rather than stretched. Several frames land near or above the price: the relative-valuation method near $34 on a sector-median 18x P/E, the two-stage excess-return model near $31, and the reverse-DCF high case near $26 to the upside, with the simple excess-return frame near $22 off an $11.18 book value and a healthy 18.2% trailing return on equity. The spread says the market is paying a fair-to-modest multiple on a business whose earnings are inflecting upward, not pricing a speculative bet.

The earnings inflection is dramatic and policy-driven. GEO Group owns and operates secure detention and processing facilities, and federal immigration policy has turned its idle and underused capacity into a growth engine. Q1 2026 revenue rose 17% to $705.2 million and EPS more than doubled to $0.29 from $0.14, beating estimates handily. ICE contracts now represent 51% of total revenue, and the secure-services segment occupancy climbed to 89% from 85% a year earlier with customer retention near 95%. The 10-K notes available bed capacity at facilities with existing contracts (FY2025 10-K, accession 0001193125-26-071747), the unused capacity that GEO is now filling at high incremental margins because the fixed cost of the facility is already in place.

The forward runway is the clearest part of the thesis. Management raised 2026 guidance to net income of $153 million to $166 million on revenue up to $3.1 billion, and pointed to the federal government's stated priority of expanding immigration-detention capacity toward roughly 100,000 beds or more while consolidating into fewer, larger facilities, exactly the kind of facility GEO owns. Filling existing beds and activating new ICE contracts (including the North Florida joint venture) drops a large share of revenue to the bottom line. A real-asset operator with idle capacity, a direct policy tailwind, and rising occupancy is a business where the operating leverage is just beginning to show, and the valuation methods bracket the price rather than scream expensive.

Bear Case

The uncomfortable truth a holder has to confront is qualitative before it is numerical: GEO Group's earnings surge rests almost entirely on a single, reversible source, federal immigration-detention policy. ICE contracts now make up 51% of revenue, which means more than half the business is a bet on the current administration's enforcement priorities continuing. Policy can change with an election, a court ruling, or a shift in appropriations, and the same political winds that drove occupancy from 85% to 89% can reverse just as fast. A business whose growth is this dependent on which way the federal government leans is not a stable compounder; it is a policy trade wearing the clothes of a real-asset operator, and the price embeds the optimistic policy path.

That concentration sits on top of two structural weaknesses. First, GEO depends on a handful of government customers, ICE, the US Marshals Service, and the Bureau of Prisons, plus state agencies, so the loss or non-renewal of even one large contract would swing results materially. The private-prison and detention industry also carries persistent reputational and regulatory risk: financing has tightened as some banks have stepped back from the sector, and policy or activist pressure can raise the cost of capital regardless of operating performance. Second, the company still carries net debt near $1.7 billion, roughly 5x trailing operating income, the legacy of its prior real-estate-investment-trust structure, which limits flexibility if the policy tailwind fades.

The numbers then frame the disconnect. At $29 the inversion implies roughly 17% operating-income growth against a current margin near 10.5%, a demanding extrapolation of the policy-driven surge. The reverse-DCF base case lands near $17, well below the price, and the engine's read is that only the relative multiple justifies the current level. In other words, strip out the assumption that immigration-detention demand keeps expanding at the recent pace and the conservative methods sit far lower. The bull case requires the policy environment to hold and capacity to keep filling; the bear case is that the price has already paid for a political cycle that, by its nature, does not last forever.

Valuation

Inverting the $29.27 price puts the embedded bet at roughly 17% operating-income growth against a current operating margin near 10.5%, with the price-implied margin near 8.9%. That is a demanding read for a business whose recent growth is policy-driven, and the engine characterizes the price as justified by the relative multiple alone.

The model X-ray clusters below to around the price. The relative-valuation method lands near $34 on a sector-median 18x P/E, the two-stage excess-return model near $31, the exit-multiple DCF near $22, the simple excess-return frame near $22 off an $11.18 book value with an 18.2% trailing ROE, and the discounted-future-market-cap method near $19. The blended landing across applicable methods is near $24, below the price. Only the relative multiple and the high-growth frames reach the current level, which is the signature of a price leaning on the recent earnings momentum continuing.

The characterization is clean: the price is justified by the relative multiple, while the asset-based and base-case growth frames land lower. GEO sits in the consumer-cyclical bucket in the model, but functionally it is a government-contract real-asset operator, so the right yardstick is occupancy, contract retention, and the policy backdrop rather than a typical cyclical multiple. The investable question is whether the 18% ROE and the policy-driven revenue surge represent a durable new run-rate or a cyclical high tied to one administration's enforcement agenda. If immigration-detention capacity keeps expanding toward the cited 100,000-bed target and occupancy holds near 89%, the relative frame is the right anchor; if policy reverses, the base-case methods near $17 to $24 mark where the value resets. Net debt near 5x operating income means the balance sheet amplifies both the upside operating leverage and the downside if the tailwind fades.

Catalysts

GEO Group reported Q1 2026 on May 6, with revenue up 17% to $705.2 million and EPS of $0.29 (more than double the year-ago $0.14 and well above the $0.19 estimate). ICE contracts reached 51% of revenue, secure-services occupancy rose to 89% from 85% a year earlier, and customer retention was near 95%. Operating expenses rose about 15% on the activation of new ICE facility contracts and higher occupancy, including the North Florida ICE detention joint venture. Management raised 2026 guidance to net income of $153 million to $166 million on revenue up to $3.1 billion.

The dominant catalyst, and the dominant risk, is federal immigration policy. The data points to watch are new ICE contract activations and bed-capacity expansion toward the cited target of roughly 100,000 detention beds or more, occupancy trends across owned and leased facilities, and contract renewals given the customer concentration. Debt reduction is a secondary lever, since the post-REIT balance sheet still carries leverage near 5x operating income, and any move on financing terms matters given the sector's tighter capital access. Election and appropriations developments are the macro variables that determine whether the policy tailwind that is driving the earnings surge persists.

Sources: GEO Group Q1 2026 results and call (Investing.com, Benzinga, Motley Fool transcript, Yahoo Finance, 2026); FY2025 10-K (accession 0001193125-26-071747).

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive GEO report on boothcheck